Anakinra

Results: 260



#Item
1EAP Reimbursement Criteria for Frequently Requested Drugs

EAP Reimbursement Criteria for Frequently Requested Drugs

Add to Reading List

Source URL: www.health.gov.on.ca

Language: English - Date: 2015-08-17 11:45:03
2UCB Presents Latest Research from Immunology Portfolio at American College of Rheumatology Annual Meeting Data presentations include:  Positive results from Period 1 of the C-EARLY™ Phase 3 study of CIMZIA® (certol

UCB Presents Latest Research from Immunology Portfolio at American College of Rheumatology Annual Meeting Data presentations include:  Positive results from Period 1 of the C-EARLY™ Phase 3 study of CIMZIA® (certol

Add to Reading List

Source URL: www.ucb-usa.com

Language: English - Date: 2016-01-20 09:39:34
3RHEUMATOLOGY  Rheumatology 2011;50:iv5–iv9 doi:rheumatology/ker241  Indirect and mixed treatment comparisons in arthritis

RHEUMATOLOGY Rheumatology 2011;50:iv5–iv9 doi:rheumatology/ker241 Indirect and mixed treatment comparisons in arthritis

Add to Reading List

Source URL: rheumatology.oxfordjournals.org

Language: English
4HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use GILOTRIF safely and effectively. See full prescribing information for GILOTRIF. ®

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use GILOTRIF safely and effectively. See full prescribing information for GILOTRIF. ®

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2016-04-18 15:38:46
5------------------------DOSAGE AND ADMINISTRATION---------------------Rheumatoid Arthritis  Recommended dose of XELJANZ is 5 mg twice daily. (2.1)  Moderate and severe renal impairment and moderate hepatic impairme

------------------------DOSAGE AND ADMINISTRATION---------------------Rheumatoid Arthritis  Recommended dose of XELJANZ is 5 mg twice daily. (2.1)  Moderate and severe renal impairment and moderate hepatic impairme

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2015-06-22 13:44:18
6HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use STIVARGA safely and effectively. See full prescribing information for STIVARGA.   Dermatological toxicity: Interr

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use STIVARGA safely and effectively. See full prescribing information for STIVARGA.  Dermatological toxicity: Interr

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2015-04-14 15:23:06
7542  CONCISE REPORT Formative research in clinical trial development: attitudes of patients with arthritis in enhancing prevention trials

542 CONCISE REPORT Formative research in clinical trial development: attitudes of patients with arthritis in enhancing prevention trials

Add to Reading List

Source URL: www.ncbi.nlm.nih.gov

Language: English
8HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CIMZIA® safely and effectively. See full prescribing information for CIMZIA.  ----------------------DOSAGE FORMS AN

HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use CIMZIA® safely and effectively. See full prescribing information for CIMZIA. ----------------------DOSAGE FORMS AN

Add to Reading List

Source URL: www.cimzia.com

Language: English - Date: 2014-10-13 13:03:47
9Important Safety Information you should know about CIMZIA® (certolizumab pegol). What is the most important information I should know about CIMZIA? CIMZIA is a medicine that affects your immune system. CIMZIA can lower

Important Safety Information you should know about CIMZIA® (certolizumab pegol). What is the most important information I should know about CIMZIA? CIMZIA is a medicine that affects your immune system. CIMZIA can lower

Add to Reading List

Source URL: www.cimzia.com

Language: English - Date: 2014-10-13 13:03:47
10HIGHLIGHTS OF PRESCRIBING INFORMATION

HIGHLIGHTS OF PRESCRIBING INFORMATION

Add to Reading List

Source URL: www.merck.com

Language: English - Date: 2015-03-26 19:23:33